全文获取类型
收费全文 | 2709篇 |
免费 | 248篇 |
国内免费 | 1篇 |
出版年
2024年 | 4篇 |
2023年 | 18篇 |
2022年 | 15篇 |
2021年 | 65篇 |
2020年 | 48篇 |
2019年 | 39篇 |
2018年 | 59篇 |
2017年 | 60篇 |
2016年 | 95篇 |
2015年 | 156篇 |
2014年 | 149篇 |
2013年 | 183篇 |
2012年 | 263篇 |
2011年 | 254篇 |
2010年 | 148篇 |
2009年 | 135篇 |
2008年 | 182篇 |
2007年 | 154篇 |
2006年 | 168篇 |
2005年 | 169篇 |
2004年 | 131篇 |
2003年 | 113篇 |
2002年 | 110篇 |
2001年 | 21篇 |
2000年 | 12篇 |
1999年 | 33篇 |
1998年 | 17篇 |
1997年 | 9篇 |
1996年 | 13篇 |
1995年 | 12篇 |
1994年 | 11篇 |
1993年 | 6篇 |
1992年 | 14篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 4篇 |
1988年 | 5篇 |
1987年 | 7篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1981年 | 3篇 |
1977年 | 3篇 |
1973年 | 3篇 |
1971年 | 3篇 |
1969年 | 3篇 |
1967年 | 4篇 |
1882年 | 2篇 |
1878年 | 2篇 |
排序方式: 共有2958条查询结果,搜索用时 31 毫秒
991.
Sofie M. Adriaanse Maja A. A. Binnewijzend Rik Ossenkoppele Betty M. Tijms Wiesje M. van der Flier Teddy Koene Lieke L. Smits Alle Meije Wink Philip Scheltens Bart N. M. van Berckel Frederik Barkhof 《PloS one》2014,9(7)
Early-onset Alzheimer’s disease (AD) patients present a different clinical profile than late-onset AD patients. This can be partially explained by cortical atrophy, although brain organization might provide more insight. The aim of this study was to examine functional connectivity in early-onset and late-onset AD patients. Resting-state fMRI scans of 20 early-onset (<65 years old), 28 late-onset (≥65 years old) AD patients and 15 “young” (<65 years old) and 31 “old” (≥65 years old) age-matched controls were available. Resting-state network-masks were used to create subject-specific maps. Group differences were examined using a non-parametric permutation test, accounting for gray-matter. Performance on five cognitive domains were used in a correlation analysis with functional connectivity in AD patients. Functional connectivity was not different in any of the RSNs when comparing the two control groups (young vs. old controls), which implies that there is no general effect of aging on functional connectivity. Functional connectivity in early-onset AD was lower in all networks compared to age-matched controls, where late-onset AD showed lower functional connectivity in the default-mode network. Functional connectivity was lower in early-onset compared to late-onset AD in auditory-, sensory-motor, dorsal-visual systems and the default mode network. Across patients, an association of functional connectivity of the default mode network was found with visuoconstruction. Functional connectivity of the right dorsal visual system was associated with attention across patients. In late-onset AD patients alone, higher functional connectivity of the sensory-motor system was associated with poorer memory performance. Functional brain organization was more widely disrupted in early-onset AD when compared to late-onset AD. This could possibly explain different clinical profiles, although more research into the relationship of functional connectivity and cognitive performance is needed. 相似文献
992.
993.
Bart P. de Kwaasteniet Chedwa Pinto Eric H. G. Ruhé Guido A. van Wingen Jan Booij Damiaan Denys 《PloS one》2014,9(11)
Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D2/3 receptor (D2/3R) binding has not been investigated in TRD subjects. We used [123I]IBZM single photon emission computed tomography (SPECT) to investigate striatal D2/3R binding in TRD. We included 6 severe TRD patients, 11 severe TRD patients on antipsychotics (TRD AP group) and 15 matched healthy controls. Results showed no significant difference (p = 0.75) in striatal D2/3R availability was found between TRD patients and healthy controls. In the TRD AP group D2/3R availability was significantly decreased (reflecting occupancy of D2/3Rs by antipsychotics) relative to TRD patients and healthy controls (p<0.001) but there were no differences in clinical symptoms between TRD AP and TRD patients. This preliminary study therefore does not provide evidence for large differences in D2/3 availability in severe TRD patients and suggests this TRD subgroup is not characterized by altered dopaminergic transmission. Atypical antipsychotics appear to have no clinical benefit in severe TRD patients who remain depressed, despite their strong occupancy of D2/3Rs. 相似文献
994.
Emmanuel Obishakin Benoit Stijlemans Julien Santi-Rocca Isabel Vandenberghe Bart Devreese Serge Muldermans Philippe Bastin Stefan Magez 《PloS one》2014,9(12)
Trypanosomes are protozoan parasites that cause diseases in humans and livestock for which no vaccines are available. Disease eradication requires sensitive diagnostic tools and efficient treatment strategies. Immunodiagnostics based on antigen detection are preferable to antibody detection because the latter cannot differentiate between active infection and cure. Classical monoclonal antibodies are inaccessible to cryptic epitopes (based on their size-150 kDa), costly to produce and require cold chain maintenance, a condition that is difficult to achieve in trypanosomiasis endemic regions, which are mostly rural. Nanobodies are recombinant, heat-stable, small-sized (15 kDa), antigen-specific, single-domain, variable fragments derived from heavy chain-only antibodies in camelids. Because of numerous advantages over classical antibodies, we investigated the use of nanobodies for the targeting of trypanosome-specific antigens and diagnostic potential. An alpaca was immunized using lysates of Trypanosoma evansi. Using phage display and bio-panning techniques, a cross-reactive nanobody (Nb392) targeting all trypanosome species and isolates tested was selected. Imunoblotting, immunofluorescence microscopy, immunoprecipitation and mass spectrometry assays were combined to identify the target recognized. Nb392 targets paraflagellar rod protein (PFR1) of T. evansi, T. brucei, T. congolense and T. vivax. Two different RNAi mutants with defective PFR assembly (PFR2RNAi and KIF9BRNAi) were used to confirm its specificity. In conclusion, using a complex protein mixture for alpaca immunization, we generated a highly specific nanobody (Nb392) that targets a conserved trypanosome protein, i.e., PFR1 in the flagella of trypanosomes. Nb392 is an excellent marker for the PFR and can be useful in the diagnosis of trypanosomiasis. In addition, as demonstrated, Nb392 can be a useful research or PFR protein isolation tool. 相似文献
995.
Colin Ruprecht Takayuki Tohge Alisdair Fernie Cara L. Mortimer Amanda Kozlo Paul D. Fraser Norma Funke Igor Cesarino Ruben Vanholme Wout Boerjan Kris Morreel Ingo Burgert Notburga Gierlinger Vincent Bulone Vera Schneider Andrea Stockero Juan Pedro Navarro Frank Pudel Bart Tambuyser James Hygate Jon Bumstead Louis Notley Staffan Persson 《Journal of visualized experiments : JoVE》2014,(87)
996.
Bart ECG de Goeij Matthias Peipp Simone de Haij Edward N van den Brink Christian Kellner Thilo Riedl Rob de Jong Tom Vink Kristin Strumane Wim K Bleeker Paul WHI Parren 《MABS-AUSTIN》2014,6(2):392-402
The human epidermal growth factor receptor (HER)2 provides an excellent target for selective delivery of cytotoxic drugs to tumor cells by antibody-drug conjugates (ADC) as has been clinically validated by ado-trastuzumab emtansine (KadcylaTM). While selecting a suitable antibody for an ADC approach often takes specificity and efficient antibody-target complex internalization into account, the characteristics of the optimal antibody candidate remain poorly understood. We studied a large panel of human HER2 antibodies to identify the characteristics that make them most suitable for an ADC approach. As a model toxin, amenable to in vitro high-throughput screening, we employed Pseudomonas exotoxin A (ETA’) fused to an anti-kappa light chain domain antibody. Cytotoxicity induced by HER2 antibodies, which were thus non-covalently linked to ETA’, was assessed for high and low HER2 expressing tumor cell lines and correlated with internalization and downmodulation of HER2 antibody-target complexes. Our results demonstrate that HER2 antibodies that do not inhibit heterodimerization of HER2 with related ErbB receptors internalize more efficiently and show greater ETA’-mediated cytotoxicity than antibodies that do inhibit such heterodimerization. Moreover, stimulation with ErbB ligand significantly enhanced ADC-mediated tumor kill by antibodies that do not inhibit HER2 heterodimerization. This suggests that the formation of HER2/ErbB-heterodimers enhances ADC internalization and subsequent killing of tumor cells. Our study indicates that selecting HER2 ADCs that allow piggybacking of HER2 onto other ErbB receptors provides an attractive strategy for increasing ADC delivery and tumor cell killing capacity to both high and low HER2 expressing tumor cells. 相似文献
997.
Edwards ML Fagan PK Towers RJ Currie BJ Sriprakash KS 《Microbes and infection / Institut Pasteur》2004,6(10):926-928
Streptococcus pyogenes (group A streptococcus, GAS) is a human-specific pathogen, which employs a large number of adhesins for colonization. Fibronectin-binding proteins (FBPs) play a major role in GAS adhesion to host cells. SfbI, a major streptococcal FBP, has been well studied. A peptide (peptide-MSG) based on this adhesin inhibits fibronectin (Fn)-binding by the pathogen. To test whether this peptide also inhibits adherence of GAS to host cells, adhesion assays were performed with strains possessing different combinations of genes for three distinct FBPs. Peptide-MSG inhibited GAS adherence to human keratinocytes (HaCaT) in a strain dependent manner. There is no consistent pattern between the effect and the ability to express one or more of the FBPs. A single peptide may be insufficient to prevent GAS adherence to host cells. 相似文献
998.
Farnesoid X receptor represses hepatic lipase gene expression 总被引:5,自引:0,他引:5
Sirvent A Verhoeven AJ Jansen H Kosykh V Darteil RJ Hum DW Fruchart JC Staels B 《Journal of lipid research》2004,45(11):2110-2115
999.
1000.